CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial of PS-341 (NSC 681239) Followed by the Addition of Doxorubicin at Progression in Advanced Adenoid Cystic Carcinoma of the Head and Neck

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00077428
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:22.761508+00:00
Published At: 2013-01-24T00:00:00+00:00
Record Updated At: 2013-01-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Recurrent Adenoid Cystic Carcinoma of the Oral Cavity", "Recurrent Salivary Gland Cancer", "Salivary Gland Adenoid Cystic Carcinoma", "Stage III Adenoid Cystic Carcinoma of the Oral Cavity", "Stage III Salivary Gland Cancer", "Stage IV Adenoid Cystic Carcinoma of the Oral Cavity", "Stage IV Salivary Gland Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2013-01-24"
protocolSection.identificationModule.nctId: "NCT00077428"
protocolSection.identificationModule.officialTitle: "Phase II Trial of PS-341 (NSC 681239) Followed by the Addition of Doxorubicin at Progression in Advanced Adenoid Cystic Carcinoma of the Head and Neck"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.